Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of TARC Serum Marker for Follow-up of Patients With Allergic Broncho-Pulmonary Aspergillosis (ABPA), Excluding Cystic Fibrosis

NCT01710930 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01710930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01710930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of TARC Serum Marker for Follow-up of Patients With Allergic Broncho-Pulmonary Aspergillosis (ABPA), Excluding Cystic Fibrosis
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
September 21, 2017
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic broncho-pulmonary aspergillosis